|
1
|
Stefani G and Slack FJ: Small non-coding
RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
|
|
3
|
Yu J, Li A, Hong SM, et al: MicroRNA
alterations of pancreatic intraepithelial neoplasias. Clin Cancer
Res. 18:981–992. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen Z, Chen LY, Dai HY, et al: miR-301a
promotes pancreatic cancer cell proliferation by directly
inhibiting Bim expression. J Cell Biochem. 113:3229–3235. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tam W, Ben-Yehuda D and Hayward WS: bic, a
novel gene activated by proviral insertions in avian leukosis
virus-induced lymphomas, is likely to function through its
noncoding RNA. Mol Cell Biol. 17:1490–1502. 1997.PubMed/NCBI
|
|
6
|
Kong W, He L, Coppola M, et al:
MicroRNA-155 regulates cell survival, growth, and chemosensitivity
by targeting FOXO3a in breast cancer. J Biol Chem. 285:17869–17879.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Babar IA, Czochor J, Steinmetz A, Weidhaas
JB, et al: Inhibition of hypoxia-induced miR-155 radiosensitizes
hypoxic lung cancer cells. Cancer Biol Ther. 12:908–914. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bakirtzi K, Hatziapostolou M,
Karagiannides I, et al: Neurotensin signaling activates
microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and
is increased in human colon tumors. Gastroenterology.
141:1749–1761. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nikiforova MN, Tseng GC, Steward D, et al:
MicroRNA expression profiling of thyroid tumors: biological
significance and diagnostic utility. J Clin Endocrinol Metab.
93:1600–1608. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Szafranska AE, Davison TS, John J, et al:
MicroRNA expression alterations are linked to tumorigenesis and
non-neoplastic processes in pancreatic ductal adenocarcinoma.
Oncogene. 26:4442–4452. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bloomston M, Frankel WL, Petrocca F, et
al: MicroRNA expression patterns to differentiate pancreatic
adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA.
297:1901–1908. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Greither T, Grochola LF, Udelnow A, et al:
Elevated expression of microRNAs 155, 203, 210 and 222 in
pancreatic tumors is associated with poorer survival. Int J Cancer.
126:73–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gironella M, Seux M, Xie MJ, et al: Tumor
protein 53-induced nuclear protein 1 expression is repressed by
miR-155, and its restoration inhibits pancreatic tumor development.
Proc Natl Acad Sci USA. 104:16170–16175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kong W, Yang H, He L, et al: MicroRNA-155
is regulated by the transforming growth factor beta/Smad pathway
and contributes to epithelial cell plasticity by targeting RhoA.
Mol Cell Biol. 28:6773–6784. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Davey GM, Heath WR and Starr R: SOCS1: a
potent and multifaceted regulator of cytokines and cell-mediated
inflammation. Tissue Antigens. 67:1–9. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang J, Zhao H, Chen J, et al:
Interferon-β-induced miR-155 inhibits osteoclast differentiation by
targeting SOCS1 and MITF. FEBS Lett. 586:3255–3262. 2012.
|
|
17
|
Huang C, Yang G, Jiang T, et al: The
effects and mechanisms of blockage of STAT3 signaling pathway on
IL-6 inducing EMT in human pancreatic cancer cells in vitro.
Neoplasma. 58:396–405. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li HD, Huang C, Huang KJ, et al: STAT3
knockdown reduces pancreatic cancer cell invasiveness and matrix
metalloproteinase-7 expression in nude mice. PLoS One.
6:e259412011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee EJ, Gusev Y, Jiang J, et al:
Expression profiling identifies microRNA signature in pancreatic
cancer. Int J Cancer. 120:1046–1054. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Habbe N, Koorstra JB, Mendell JT, et al:
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia.
Cancer Biol Ther. 8:340–346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pedersen IM, Otero D, Kao E, et al:
Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of
B cell lymphomas. EMBO Mol Med. 1:288–295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Costinean S, Sandhu SK, Pedersen IM, et
al: Src homology 2 domain-containing inositol-5-phosphatase and
CCAAT enhancer-binding protein β are targeted by miR-155 in B cells
of Eμ-MiR-155 transgenic mice. Blood. 114:1374–1382.
2009.PubMed/NCBI
|
|
23
|
Zhang P, Bill K, Liu J, Young E, et al:
MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and
enhances β-catenin signaling. Cancer Res. 72:1751–1762.
2012.PubMed/NCBI
|
|
24
|
Jiang S, Zhang HW, Lu MH, et al:
MicroRNA-155 functions as an OncomiR in breast cancer by targeting
the suppressor of cytokine signaling 1 gene. Cancer Res.
70:3119–3127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang C, Cao J, Huang KJ, et al:
Inhibition of STAT3 activity with AG490 decreases the invasion of
human pancreatic cancer cell in vitro. Cancer Sci. 97:1417–1423.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang S, Zhang LF, Zhang HW, et al: A
novel miR-155/miR-143 cascade controls glycolysis by regulating
hexokinase 2 in breast cancer cells. EMBO J. 31:1985–1998. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Su C, Hou Z, Zhang C, et al: Ectopic
expression of microRNA-155 enhances innate antiviral immunity
against HBV infection in human hepatoma cells. Virol J. 8:3542011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Han ZB, Chen HY, Fan JW, et al:
Up-regulation of microRNA-155 promotes cancer cell invasion and
predicts poor survival of hepatocellular carcinoma following liver
transplantation. J Cancer Res Clin Oncol. 138:153–161. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sasi W, Jiang WG, Sharma A and Mokbel K:
Higher expression levels of SOCS 1,3,4,7 are associated with
earlier tumour stage and better clinical outcome in human breast
cancer. BMC Cancer. 10:1782010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang J, Li H, Yu JP, et al: Role of SOCS1
in tumor progression and therapeutic application. Int J Cancer.
130:1971–1980. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ryu JK, Hong SM, Karikari CA, et al:
Aberrant microRNA-155 expression is an early event in the multistep
progression of pancreatic adenocarcinoma. Pancreatology. 10:66–73.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Panarelli NC, Chen YT, Zhou XK, et al:
MicroRNA expression aids the preoperative diagnosis of pancreatic
ductal adenocarcinoma. Pancreas. 41:685–690. 2012.PubMed/NCBI
|
|
33
|
Wang J, Chen J, Chang P, et al: microRNAs
in plasma of pancreatic ductal adenocarcinoma patients as novel
blood-based biomarkers of disease. Cancer Prev Res. 2:807–813.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li CL, Nie H, Wang M, et al: microRNA-155
is downregulated in gastric cancer cells and involved in cell
metastasis. Oncol Rep. 27:1960–1966. 2012.PubMed/NCBI
|
